Dr Thomas Bachelot
- Specialty
- Oncologist, breast and gynecology expert
- Title
- Assistant department coordinator
- Hospital
- Centre Léon Bérard (Lyon)
- Latest articles
-
- BRCA1/2, PALB2 mutations and first-line CDK4/6 inhibitor efficacy in HR+ metastatic breast cancer. (Feb 16, 2026)
- Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03. (Feb 1, 2026)
- Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the recurrence score® in node-positive breast cancer: Independent validation in the PACS-01 trial. (Jan 17, 2026)
- Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort. (Jan 17, 2026)
- Remotely supervised online cognitive training to reduce cognitive difficulties following chemotherapy in patients treated for localized breast cancer: Protocol of the Cog-Stim2 multicenter randomized controlled trial. (Nov 13, 2025)